GET THE APP

Journal of Clinical Trials

Journal of Clinical Trials
Open Access

ISSN: 2167-0870

+44 20 3868 9735

Journal of Clinical Trials : Citations & Metrics Report

Articles published in Journal of Clinical Trials have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Trials has got h-index 17, which means every article in Journal of Clinical Trials has got 17 average citations.

Following are the list of articles that have cited the articles published in Journal of Clinical Trials.

  2021 2020 2019 2018 2017

Year wise published articles

79 78 38 20 35

Year wise citations received

171 166 120 127 143
Journal total citations count 1222
Journal impact factor 2.76
Journal 5 years impact factor 3.07
Journal cite score 3.14
Journal h-index 17
Journal h-index since 2017 13
Important citations

Research and reviews: journal of engineering and technology genetic syndromes and involvement of gene therapy

Fibroblast growth factor in extremities

Occurrence and molecular characterization of pepper veinal mottle virus from solanaceous crops

pesticide knowledge and safety practices among farm workers in kuwait: results of a survey

Clinical trial participation in india

Clinical trial participation in india

Frequency of increase in cardiac troponin levels after peripheral arterial operations (carotid endarterectomy, abdominal aorta procedure, distal bypass) and their effect on medical management

Healthcare professionals' awareness and knowledge of adverse drug reactions and pharmacovigilance.

Bridging the cultural gap between eastern and western thinking: from an occupational therapy perspective

Early discharge in low-risk patients hospitalized for acute coronary syndromes: feasibility, safety and reasons for prolonged length of stay

exploration of traumatic brain-inflammatory alterations in alzheimer?s disease pateint

Thrombus straddling patent foramen ovale and massive pulmonary embolism.

Therapeutic implications of the molecular and immune landscape of triple-negative breast cancer.

Cullin7 enhances resistance to trastuzumab therapy in her2 positive breast cancer via degrading irs-1 and downregulating igfbp-3 to activate the pi3k/akt pathway.

Epigenetics - role as biomarker in cancer diagnosis

Epigenetics - role as biomarker in cancer diagnosis

Stakeholders' perspectives on research integrity training practices: a qualitative study.

Adverse drug reaction reporting by community pharmacists-the barriers and facilitators.

Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in al-madinah al-munawwarah, kingdom of saudi arabia

Clinical trial participation in india

Relevant Topics